- Home
- AEHL vs NVNO Comparison
AEHL vs NVNO Comparison
Compare AEHL & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- NVNO
- Stock Information
- Founded
- AEHL 1993
- NVNO 1987
- Country
- AEHL China
- NVNO United States
- Employees
- AEHL N/A
- NVNO N/A
- Industry
- AEHL Building Materials
- NVNO Medical/Dental Instruments
- Sector
- AEHL Industrials
- NVNO Health Care
- Exchange
- AEHL Nasdaq
- NVNO Nasdaq
- Market Cap
- AEHL 17.3M
- NVNO 16.7M
- IPO Year
- AEHL 2007
- NVNO N/A
- Fundamental
- Price
- AEHL $1.85
- NVNO $0.72
- Analyst Decision
- AEHL
- NVNO
- Analyst Count
- AEHL 0
- NVNO 0
- Target Price
- AEHL N/A
- NVNO N/A
- AVG Volume (30 Days)
- AEHL 327.4K
- NVNO 316.7K
- Earning Date
- AEHL 12-26-2025
- NVNO 10-31-2025
- Dividend Yield
- AEHL N/A
- NVNO N/A
- EPS Growth
- AEHL N/A
- NVNO N/A
- EPS
- AEHL N/A
- NVNO N/A
- Revenue
- AEHL $98,773,000.00
- NVNO N/A
- Revenue This Year
- AEHL N/A
- NVNO N/A
- Revenue Next Year
- AEHL N/A
- NVNO N/A
- P/E Ratio
- AEHL N/A
- NVNO N/A
- Revenue Growth
- AEHL 36.99
- NVNO N/A
- 52 Week Low
- AEHL $1.79
- NVNO $0.67
- 52 Week High
- AEHL $15.60
- NVNO $5.62
- Technical
- Relative Strength Index (RSI)
- AEHL 29.75
- NVNO 31.95
- Support Level
- AEHL $2.76
- NVNO $0.68
- Resistance Level
- AEHL $3.14
- NVNO $0.76
- Average True Range (ATR)
- AEHL 0.47
- NVNO 0.06
- MACD
- AEHL -0.18
- NVNO 0.03
- Stochastic Oscillator
- AEHL 0.00
- NVNO 18.99
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.